John R. Stuelpnagel's most recent trade in 10x Genomics Inc - Ordinary Shares - Class A was a trade of 15,357 Class A Common Stock done . Disclosure was reported to the exchange on June 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 15,357 | 359,607 (1%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 8,649 | 344,250 (1%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 4,661 | 4,661 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 1,865 | 335,601 (1%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 54.89 per share. | 05 Jun 2023 | 10,000 | 333,736 (1%) | 0% | 54.9 | 548,894 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 5,300 | 5,300 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 2,120 | 343,736 (1%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 150.51 per share. | 01 Dec 2021 | 2,000 | 349,616 (1%) | 0% | 150.5 | 301,022 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 151.10 per share. | 01 Dec 2021 | 1,700 | 347,916 (1%) | 0% | 151.1 | 256,869 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 151.79 per share. | 01 Dec 2021 | 1,100 | 346,816 (1%) | 0% | 151.8 | 166,973 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 155.55 per share. | 01 Dec 2021 | 100 | 346,616 (1%) | 0% | 155.6 | 15,555 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 154.02 per share. | 01 Dec 2021 | 100 | 346,716 (1%) | 0% | 154.0 | 15,402 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 158.79 per share. | 16 Nov 2021 | 3,052 | 352,764 (1%) | 0% | 158.8 | 484,623 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 159.80 per share. | 16 Nov 2021 | 1,048 | 351,716 (1%) | 0% | 159.8 | 167,472 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 157.55 per share. | 16 Nov 2021 | 800 | 355,816 (1%) | 0% | 157.5 | 126,038 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 160.32 per share. | 16 Nov 2021 | 100 | 351,616 (1%) | 0% | 160.3 | 16,032 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 163.89 per share. | 01 Nov 2021 | 2,906 | 356,916 (1%) | 0% | 163.9 | 476,264 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 163.10 per share. | 01 Nov 2021 | 1,494 | 359,822 (1%) | 0% | 163.1 | 243,669 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 164.58 per share. | 01 Nov 2021 | 300 | 356,616 (1%) | 0% | 164.6 | 49,374 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 160.33 per share. | 01 Nov 2021 | 100 | 361,516 (1%) | 0% | 160.3 | 16,033 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 160.75 per share. | 01 Nov 2021 | 100 | 361,416 (1%) | 0% | 160.8 | 16,075 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 161.52 per share. | 01 Nov 2021 | 100 | 361,316 (1%) | 0% | 161.5 | 16,152 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 150.51 per share. | 18 Oct 2021 | 4,400 | 362,216 (1%) | 0% | 150.5 | 662,260 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 151.41 per share. | 18 Oct 2021 | 300 | 361,916 (1%) | 0% | 151.4 | 45,424 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 152.20 per share. | 18 Oct 2021 | 300 | 361,616 (1%) | 0% | 152.2 | 45,659 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 150.18 per share. | 07 Oct 2021 | 5,000 | 366,616 (1%) | 0% | 150.2 | 750,899 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 156.72 per share. | 16 Sep 2021 | 1,631 | 372,785 (1%) | 0% | 156.7 | 255,613 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 155.69 per share. | 16 Sep 2021 | 1,500 | 374,416 (1%) | 0% | 155.7 | 233,534 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 157.75 per share. | 16 Sep 2021 | 1,169 | 371,616 (1%) | 0% | 157.7 | 184,404 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 154.45 per share. | 16 Sep 2021 | 700 | 375,916 (1%) | 0% | 154.5 | 108,117 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 159.93 per share. | 16 Aug 2021 | 2,790 | 382,216 (1%) | 0% | 159.9 | 446,216 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 158.84 per share. | 16 Aug 2021 | 1,310 | 385,006 (1%) | 0% | 158.8 | 208,076 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 160.56 per share. | 16 Aug 2021 | 600 | 381,616 (1%) | 0% | 160.6 | 96,338 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 157.31 per share. | 16 Aug 2021 | 300 | 386,313 (1%) | 0% | 157.3 | 47,194 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 179.53 per share. | 02 Aug 2021 | 1,140 | 389,376 (1%) | 0% | 179.5 | 204,669 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 181.47 per share. | 02 Aug 2021 | 1,100 | 387,316 (1%) | 0% | 181.5 | 199,620 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 178.48 per share. | 02 Aug 2021 | 1,100 | 390,516 (1%) | 0% | 178.5 | 196,323 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 180.33 per share. | 02 Aug 2021 | 960 | 388,416 (1%) | 0% | 180.3 | 173,115 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 182.74 per share. | 02 Aug 2021 | 400 | 386,916 (1%) | 0% | 182.7 | 73,096 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 183.90 per share. | 02 Aug 2021 | 200 | 386,716 (1%) | 0% | 183.9 | 36,780 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 184.99 per share. | 02 Aug 2021 | 100 | 386,616 (1%) | 0% | 185.0 | 18,499 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 170.83 per share. | 16 Jul 2021 | 2,190 | 392,216 (1%) | 0% | 170.8 | 374,118 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 169.75 per share. | 16 Jul 2021 | 1,710 | 394,406 (1%) | 0% | 169.7 | 290,264 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 171.44 per share. | 16 Jul 2021 | 600 | 391,616 (1%) | 0% | 171.4 | 102,864 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 168.57 per share. | 16 Jul 2021 | 500 | 396,116 (1%) | 0% | 168.6 | 84,283 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 189.94 per share. | 01 Jul 2021 | 1,600 | 400,016 (1%) | 0% | 189.9 | 303,909 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 190.87 per share. | 01 Jul 2021 | 1,300 | 398,716 (1%) | 0% | 190.9 | 248,127 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 191.97 per share. | 01 Jul 2021 | 700 | 398,016 (1%) | 0% | 192.0 | 134,381 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 193.51 per share. | 01 Jul 2021 | 700 | 397,316 (1%) | 0% | 193.5 | 135,454 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 194.29 per share. | 01 Jul 2021 | 500 | 396,816 (1%) | 0% | 194.3 | 97,143 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 196.00 per share. | 01 Jul 2021 | 200 | 396,616 (1%) | 0% | 196 | 39,200 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 200.23 per share. | 17 Jun 2021 | 1,700 | 403,016 (1%) | 0% | 200.2 | 340,393 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 201.03 per share. | 17 Jun 2021 | 1,000 | 402,016 (1%) | 0% | 201.0 | 201,026 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 199.30 per share. | 17 Jun 2021 | 600 | 404,716 (1%) | 0% | 199.3 | 119,581 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 197.75 per share. | 17 Jun 2021 | 500 | 405,316 (1%) | 0% | 197.8 | 98,875 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 196.75 per share. | 17 Jun 2021 | 400 | 405,816 (1%) | 0% | 196.7 | 78,699 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 202.18 per share. | 17 Jun 2021 | 300 | 401,716 (1%) | 0% | 202.2 | 60,653 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 195.30 per share. | 17 Jun 2021 | 200 | 406,216 (1%) | 0% | 195.3 | 39,059 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 190.97 per share. | 17 Jun 2021 | 100 | 406,516 (1%) | 0% | 191.0 | 19,097 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 191.97 per share. | 17 Jun 2021 | 100 | 406,416 (1%) | 0% | 192.0 | 19,197 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 203.42 per share. | 17 Jun 2021 | 100 | 401,616 (1%) | 0% | 203.4 | 20,342 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 1,563 | 1,563 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 625 | 406,616 (1%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 175.77 per share. | 01 Jun 2021 | 2,400 | 406,691 (1%) | 0% | 175.8 | 421,839 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 171.58 per share. | 01 Jun 2021 | 1,597 | 411,894 (1%) | 0% | 171.6 | 274,018 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 174.80 per share. | 01 Jun 2021 | 1,500 | 409,091 (1%) | 0% | 174.8 | 262,200 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 172.56 per share. | 01 Jun 2021 | 703 | 411,191 (1%) | 0% | 172.6 | 121,307 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 173.72 per share. | 01 Jun 2021 | 600 | 410,591 (1%) | 0% | 173.7 | 104,232 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 178.21 per share. | 01 Jun 2021 | 300 | 406,291 (1%) | 0% | 178.2 | 53,464 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 179.78 per share. | 01 Jun 2021 | 300 | 405,991 (1%) | 0% | 179.8 | 53,933 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 176.72 per share. | 01 Jun 2021 | 100 | 406,591 (1%) | 0% | 176.7 | 17,672 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 140.34 per share. | 17 May 2021 | 2,600 | 417,891 (1%) | 0% | 140.3 | 364,882 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 141.36 per share. | 17 May 2021 | 1,800 | 416,091 (1%) | 0% | 141.4 | 254,452 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 142.48 per share. | 17 May 2021 | 1,000 | 415,091 (1%) | 0% | 142.5 | 142,482 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 143.44 per share. | 17 May 2021 | 1,000 | 414,091 (1%) | 0% | 143.4 | 143,440 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 144.48 per share. | 17 May 2021 | 600 | 413,491 (1%) | 0% | 144.5 | 86,691 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 139.59 per share. | 17 May 2021 | 500 | 420,491 (1%) | 0% | 139.6 | 69,793 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 191.83 per share. | 03 May 2021 | 2,880 | 423,691 (1%) | 0% | 191.8 | 552,462 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 192.54 per share. | 03 May 2021 | 2,200 | 421,491 (1%) | 0% | 192.5 | 423,583 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 190.53 per share. | 03 May 2021 | 1,320 | 426,571 (2%) | 0% | 190.5 | 251,504 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 189.25 per share. | 03 May 2021 | 600 | 427,891 (2%) | 0% | 189.3 | 113,551 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 193.84 per share. | 03 May 2021 | 300 | 421,191 (1%) | 0% | 193.8 | 58,152 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 198.09 per share. | 03 May 2021 | 100 | 420,991 (1%) | 0% | 198.1 | 19,809 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 194.90 per share. | 03 May 2021 | 100 | 421,091 (1%) | 0% | 194.9 | 19,490 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 193.86 per share. | 16 Apr 2021 | 1,600 | 430,184 (2%) | 0% | 193.9 | 310,172 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 190.70 per share. | 16 Apr 2021 | 1,500 | 433,391 (2%) | 0% | 190.7 | 286,056 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 194.83 per share. | 16 Apr 2021 | 1,393 | 428,791 (2%) | 0% | 194.8 | 271,394 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 189.97 per share. | 16 Apr 2021 | 1,100 | 434,891 (2%) | 0% | 190.0 | 208,971 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 192.85 per share. | 16 Apr 2021 | 926 | 431,784 (2%) | 0% | 192.8 | 178,578 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 191.85 per share. | 16 Apr 2021 | 681 | 432,710 (2%) | 0% | 191.9 | 130,650 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 195.74 per share. | 16 Apr 2021 | 300 | 428,491 (2%) | 0% | 195.7 | 58,723 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 185.21 per share. | 01 Apr 2021 | 3,487 | 436,591 (2%) | 0% | 185.2 | 645,844 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 184.22 per share. | 01 Apr 2021 | 2,272 | 440,078 (2%) | 0% | 184.2 | 418,539 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 183.19 per share. | 01 Apr 2021 | 700 | 442,350 (2%) | 0% | 183.2 | 128,233 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 185.90 per share. | 01 Apr 2021 | 600 | 435,991 (2%) | 0% | 185.9 | 111,542 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 180.27 per share. | 01 Apr 2021 | 241 | 443,250 (2%) | 0% | 180.3 | 43,446 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 181.82 per share. | 01 Apr 2021 | 200 | 443,050 (2%) | 0% | 181.8 | 36,365 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 172.29 per share. | 17 Mar 2021 | 1,266 | 444,291 (2%) | 0% | 172.3 | 218,114 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 169.27 per share. | 17 Mar 2021 | 1,100 | 446,870 (2%) | 0% | 169.3 | 186,199 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 167.98 per share. | 17 Mar 2021 | 920 | 447,970 (2%) | 0% | 168.0 | 154,540 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | John R. Stuelpnagel | Director | Sale of securities on an exchange or to another person at price $ 170.09 per share. | 17 Mar 2021 | 813 | 446,057 (2%) | 0% | 170.1 | 138,281 | Class A Common Stock |